During the past decade, Instituto Urologico Buenos Aires conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto Urologico Buenos Aires" are "Overactive Bladder" (2 trials) and "Urinary Incontinence" (1 trials). Many other conditions were trialed in "Instituto Urologico Buenos Aires" in a lesser frequency.

Most popular intervention types in "Instituto Urologico Buenos Aires" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Botulinum toxin type A" (1 trials), "Fesoterodine 4mg" (1 trials) and "Fesoterodine 8mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Urologico Buenos Aires" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Urologico Buenos Aires". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Instituto Urologico Buenos Aires, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Urologico Buenos Aires, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".